Omega is a real estate investment trust that invests in the long-term
healthcare industry, primarily in skilled nursing and assisted living
facilities. Its portfolio of assets is operated by a diverse group of
healthcare companies, predominantly in a triple-net lease structure. The
assets span all regions within the US, as well as in the UK.
The following table presents a reconciliation of Omega's guidance
regarding Adjusted FFO to projected GAAP earnings.
Note: All per share numbers rounded to 2 decimals.
Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega")
today announced that its tenant, 4 West Holdings, Inc. ("Orianna")
and certain of its affiliates (the "Debtors"), commenced
voluntary Chapter 11 proceedings in the United States Bankruptcy Court
for the Northern District of Texas, Dallas Division.
The action is styled In re 4 West Holdings, Inc., Case No.
18-30777-hdh11 (Bankr. N.D. Tex.). Copies of all materials filed in this
action are available at http://www.omnimgt.com/4west.
C. Taylor Pickett, Omega's Chief Executive Officer, stated, "We
supported Orianna's decision to pursue a restructuring in the context of
a Chapter 11 proceeding as we believe that this will ensure that the
interests of the residents will be protected while at the same time
providing for an orderly and balanced process that will address and
definitively resolve the interests and legitimate concerns of the
various constituencies involved in Orianna's business. As described in
Orianna's filings with the Bankruptcy Court, Omega has entered into a
Restructuring Support Agreement ("RSA") that will form the basis
for Orianna's restructuring. The RSA provides for the recommencement of
partial rent payments at $1.0 million per month (prorated for March) and
establishes a specific timeline for the implementation of Orianna's
planned restructuring."
While subject to Bankruptcy Court approval, the RSA provides for the
orderly transition to new operators of 23 of the 42 facilities Orianna
currently leases from Omega. The RSA contemplates that these transfers
will be approved by the Bankruptcy Court within 45 days and thereafter
such transfers will be completed promptly upon obtaining any required
state-level regulatory approvals. The RSA also provides for the sale of
the remaining 19 facilities pursuant to a plan of reorganization to be
confirmed by the Bankruptcy Court. The RSA contemplates that the plan
confirmation will occur within 110 days and that such sale will be
concluded by the end of 2018.
In order to provide liquidity to the Debtors during their Chapter 11
proceedings, Omega has provided a commitment for up to $30 million in
debtor-in-possession ("DIP") financing. Subject to Bankruptcy
Court approval, this DIP financing would be used to repay in full the
Debtors' current working capital lender and to provide the Debtors' with
additional liquidity to fund on-going business operations. Omega's
commitment to provide the DIP financing is conditioned on obtaining
first priority liens on the Debtors' assets and being granted
superpriority claim status in the bankruptcy cases. It is anticipated
that the Bankruptcy Court will provide an interim ruling on this request
within several days and a final ruling within 30 days.
Mr. Pickett noted, "We continue to expect that our post-transition
restructuring rent for the transition portfolio and rent equivalent for
the 19 properties to be sold will ultimately be in our
previously-estimated range of $32.0 million - $38.0 million. Last year,
we recorded impairments on our Orianna direct financing leases
reflecting assumed annual rents in that range, rental yields between 9%
and 10%, and certain assumptions regarding current and projected
operating performance of the facilities, coverage ratios and bed values.
We do not believe Orianna's filing for bankruptcy protection materially
affects the fair value of the facilities, and accordingly, at this time
we do not expect to record further impairments on the Orianna direct
financing leases as a result."
Regarding guidance, Mr. Pickett added, "Our previously announced
guidance assumed the Company will not be recording revenue related to
its Orianna portfolio for the majority of 2018. Orianna's Chapter 11
filing does not change our estimates and, accordingly, we reaffirm the
adjusted funds from operations ("Adjusted FFO") guidance
contained in our February 13, 2018 earnings release in the range of
$2.96 - $3.06. Of course, our actual results will depend on the timing
of the transitions and sales contemplated by the RSA."
2018 Annual Adjusted FFO Guidance Range (per diluted
common share)
Full Year
Net Income
$1.43 - $1.53
Depreciation
1.45
Gain on assets sold
-
Real estate impairment
-
FFO
$2.88 - $2.98
Adjustments:
Acquisition/transaction costs
-
Interest – refinancing costs
-
Stock-based compensation expense
0.08
Adjusted FFO
$2.96 - $3.06
The Company's Adjusted FFO guidance for 2018 reflects the impact of
approximately $100 million of planned capital renovation projects, the
sale of $87 million of assets held for sale, approximately $300 million
of potential divestitures and the redeployment of capital from asset
sales. The Company's guidance excludes the impact of gains and losses
from the sale of assets, certain revenue and expense items, interest
refinancing expense, capital transactions, acquisition costs, and
additional provisions for uncollectible accounts, if any. The Company
may, from time to time, update its publicly announced Adjusted FFO
guidance, but it is not obligated to do so.
The Company's guidance is based on a number of assumptions, which are
subject to change and many of which are outside the Company's control.
If actual results vary from these assumptions, the Company's
expectations may change. Without limiting the generality of the
foregoing, the timing and completion of acquisitions, divestitures,
capital and financing transactions, and variations in stock-based
compensation expense may cause actual results to vary materially from
our current expectations. There can be no assurance that the Company
will achieve its projected results.
This press release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements regarding Omega's or its tenants', operators', borrowers' or
managers' expected future financial condition, results of operations,
cash flows, funds from operations, dividends and dividend plans,
financing opportunities and plans, capital markets transactions,
business strategy, budgets, projected costs, operating metrics, capital
expenditures, competitive positions, acquisitions, investment
opportunities, dispositions, facility transitions, growth opportunities,
expected lease income, continued qualification as a real estate
investment trusts ("REIT"), plans and objectives of management for
future operations and statements that include words such as
"anticipate," "if," "believe," "plan," "estimate," "expect," "intend,"
"may," "could," "should," "will" and other similar expressions are
forward-looking statements. These forward-looking statements are
inherently uncertain, and actual results may differ from Omega's
expectations. Omega does not undertake a duty to update these
forward-looking statements, which speak only as of the date on which
they are made.
Omega's actual results may differ materially from those reflected in
such forward-looking statements as a result of a variety of factors,
including, among other things: (i) uncertainties relating to the
business operations of the operators of Omega's properties, including
those relating to reimbursement by third-party payors, regulatory
matters and occupancy levels; (ii) regulatory and other changes in the
healthcare sector; (iii) changes in the financial position of Omega's
operators; (iv) the ability of any of Omega's operators in bankruptcy to
reject unexpired lease obligations, modify the terms of Omega's
mortgages and impede the ability of Omega to collect unpaid rent or
interest during the pendency of a bankruptcy proceeding and retain
security deposits for the debtor's obligations; (v) the availability and
cost of capital; (vi) changes in Omega's credit ratings and the ratings
of its debt securities; (vii) competition in the financing of healthcare
facilities; (viii) Omega's ability to maintain its status as a REIT;
(ix) Omega's ability to sell assets held for sale or complete potential
asset sales on a timely basis and on terms that allow Omega to realize
the carrying value of these assets; (x) Omega's ability to re-lease,
otherwise transition or sell underperforming assets on a timely basis
and on terms that allow Omega to realize the carrying value of these
assets; (xi) the effect of economic and market conditions generally, and
particularly in the healthcare industry; (xii) the potential impact of
changes in the SNF and assisted living facility ("ALF") market or local
real estate conditions on the Company's ability to dispose of assets
held for sale for the anticipated proceeds or on a timely basis, or to
redeploy the proceeds therefrom on favorable terms; (xiii) changes in
interest rates; (xiv) changes in tax laws and regulations affecting
REITs, (xv) risks and uncertainties regarding Orianna's bankruptcy,
including without limitation, the potential that the Bankruptcy Court
may not approve the RSA or not approve the RSA on the terms contemplated
by Omega, potential delays in the anticipated transition and sale of the
Orianna facilities, potential objections from other creditors of
Orianna, and possibility of declines in the operating performance of the
Orianna facilities resulting from the bankruptcy process and (xvi) other
factors identified in Omega's filings with the Securities and Exchange
Commission. Statements regarding future events and developments and
Omega's future performance, as well as management's expectations,
beliefs, plans, estimates or projections relating to the future, are
forward looking statements. Omega undertakes no obligation to update any
forward-looking statements contained in this announcement.
Funds From Operations ("FFO") and Adjusted FFO are non-GAAP financial
measures. For purposes of the Securities and Exchange Commission's
Regulation G, a non-GAAP financial measure is a numerical measure of a
company's historical or future financial performance, financial position
or cash flows that exclude amounts, or is subject to adjustments that
have the effect of excluding amounts, that are included in the most
directly comparable financial measure calculated and presented in
accordance with GAAP in the statement of operations, balance sheet or
statement of cash flows (or equivalent statements) of the company, or
include amounts, or is subject to adjustments that have the effect of
including amounts, that are excluded from the most directly comparable
financial measure so calculated and presented. As used in this press
release, GAAP refers to generally accepted accounting principles in the
United States of America. Pursuant to the requirements of Regulation G,
the Company has provided reconciliations of the non-GAAP financial
measures to the most directly comparable GAAP financial measures.
The Company calculates and reports FFO in accordance with the definition
and interpretive guidelines issued by the National Association of Real
Estate Investment Trusts ("NAREIT"), and consequently, FFO is defined as
net income (computed in accordance with GAAP), adjusted for the effects
of asset dispositions and certain non-cash items, primarily depreciation
and amortization and impairments on real estate assets, and after
adjustments for unconsolidated partnerships and joint ventures.
Adjustments for unconsolidated partnerships and joint ventures will be
calculated to reflect funds from operations on the same basis. The
Company believes that FFO and Adjusted FFO are important supplemental
measures of its operating performance. Because the historical cost
accounting convention used for real estate assets requires depreciation
(except on land), such accounting presentation implies that the value of
real estate assets diminishes predictably over time, while real estate
values instead have historically risen or fallen with market conditions.
The term FFO was designed by the real estate industry to address this
issue. FFO described herein is not necessarily comparable to FFO of
other real estate investment trusts, or REITs, that do not use the same
definition or implementation guidelines or interpret the standards
differently from the Company.
Adjusted FFO is calculated as FFO excluding the impact of non-cash
stock-based compensation and certain revenue and expense items
identified above. The Company believes these measures provide an
enhanced measure of the operating performance of the Company's core
portfolio as a REIT. The Company's computation of Adjusted FFO is not
comparable to the NAREIT definition of FFO or to similar measures
reported by other REITs, but the Company believes that they are
appropriate measures for this Company.
The Company uses these non-GAAP measures among the criteria to measure
the operating performance of its business. The Company also uses
Adjusted FFO among the performance metrics for performance-based
compensation of officers. The Company further believes that by excluding
the effect of depreciation, amortization, impairments on real estate
assets and gains or losses from sales of real estate, all of which are
based on historical costs and which may be of limited relevance in
evaluating current performance, FFO can facilitate comparisons of
operating performance between periods and between other REITs. The
Company offers these measures to assist the users of its financial
statements in analyzing its operating performance and not as measures of
liquidity or cash flow. These non-GAAP measures are not measures of
financial performance under GAAP and should not be considered as
measures of liquidity, alternatives to net income or indicators of any
other performance measure determined in accordance with GAAP. Investors
and potential investors in the Company's securities should not rely on
these non-GAAP measures as substitutes for any GAAP measure, including
net income.